Miles Capital’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Miles Capital’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-16,005	Closed	-$225K	–	201
2017 Q3	$225K	Buy	+16,005	New	+$145K	0.13%	154

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Miles Capital's SPPI Position: Q4 2017 in Review

Miles Capital sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2017, closing a stake of 16,005 shares — an estimated $225K sold.

Miles Capital first reported a position in SPPI in Q3 2017 and held it in 1 quarter. The position peaked at $225K in Q3 2017. 157 funds tracked by Wall St. Rank hold SPPI as of Q4 2017.

Miles Capital reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Miles Capital sold 16,005 Spectrum Pharmaceuticals Inc shares in Q4 2017, an estimated $225K.
Miles Capital first reported a position in Spectrum Pharmaceuticals Inc in Q3 2017 and held it in 1 quarter.
Miles Capital's Spectrum Pharmaceuticals Inc position peaked at $225K in Q3 2017.
157 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2017.

Based on Miles Capital's 13F filing for Q4 2017, filed 31 Jan 2018.